{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-007383","form_type":"8-K","ticker":"ANRO","cik":"0001999480","company_name":"Alto Neuroscience, Inc.","filed_at":"2025-01-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.744438+00:00","generated_at":"2026-05-28T00:25:12.485864+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Alto Neuroscience expands credit facility to $75M, extends maturity to 2029","bullets":["Maturity extended from Dec 2026 to Jan 2029; max facility raised from $35M to $75M.","$20M funded at closing; up to $30M tranche contingent on milestones, $25M tranche subject to lender approval.","Interest: Prime +1.45% (floor 8.45%) plus 1% PIK; cash runway covenant begins Jan 2026.","Loan conversion feature: up to $9M convertible at $10.49 (first $4M) and $4.8259 (next $5M).","Warrants repriced to $3.7122; new warrant issued for additional shares expiring Jan 2035."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-007383","json":"https://secwatch.observer/filing/0001193125-25-007383.json","markdown":"https://secwatch.observer/filing/0001193125-25-007383.md","text":"https://secwatch.observer/filing/0001193125-25-007383.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1999480/000119312525007383/0001193125-25-007383-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1999480/000119312525007383/d891653d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T00:25:12.485864+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}